Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Needs More Time To Comply With Sunscreen Testing, Labeling Rule

This article was originally published in The Tan Sheet

Executive Summary

A “shortage of sunscreen products” could occur in summer 2012 unless FDA allows manufacturers six additional months to comply with the testing and labeling requirements imposed in a recent final rule, trade groups say.

You may also be interested in...



Cold Indication For Antihistamines Targeted In Regulatory Agenda

The latest regulatory agenda says FDA targets issuing proposed rules on OTC antimicrobial hand wash products in February and leave-on antiseptics in July, and in February to finalize an OTC monograph for oral bronchodilator in combination with expectorants or oral nasal decongestants.

Cold Indication For Antihistamines Targeted In Regulatory Agenda

The latest regulatory agenda says FDA targets issuing proposed rules on OTC antimicrobial hand wash products in February and leave-on antiseptics in July, and in February to finalize an OTC monograph for oral bronchodilator in combination with expectorants or oral nasal decongestants.

In Brief

Hi-Tech absorbs hit from Sandy; Meda strikes MidNite deal; Sunscreen labeling due date nears; ChromaDex picks up Spherix Consulting; Chemi Pharmaceutical allegedly falsified tests; Actavis exec Boothe joins Perrigo.

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS105266

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel